| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |